Search Results - "Kazanov, Diana"

Refine Results
  1. 1

    Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers by Shapira, Shiran, Pleban, Shlomo, Kazanov, Diana, Tirosh, Peter, Arber, Nadir

    Published in PloS one (08-06-2016)
    “…Terpinen-4-ol, a naturally occurring monoterpene is the main bioactive component of tea-tree oil and has been shown to have many biological activities. To…”
    Get full text
    Journal Article
  2. 2

    Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells by LEV-ARI, Shahar, STRIER, Ludmila, KAZANOV, Diana, MADAR-SHAPIRO, Liora, DVORY-SOBOL, Hadas, PINCHUK, Ilya, MARIAN, Brigitte, LICHTENBERG, Dov, ARBER, Nadir

    Published in Clinical cancer research (15-09-2005)
    “…Purpose: Multiple studies have indicated that cyclooxygenase-2 (COX-2) inhibitors may prevent colon cancer, which is one of the leading causes of cancer death…”
    Get full text
    Journal Article
  3. 3

    CD24 Is a New Oncogene, Early at the Multistep Process of Colorectal Cancer Carcinogenesis by Sagiv, Eyal, Memeo, Lorenzo, Karin, Adi, Kazanov, Diana, Jacob–Hirsch, Jasmin, Mansukhani, Mahesh, Rechavi, Gidi, Hibshoosh, Hanina, Arber, Nadir

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-2006)
    “…Background & Aims: The aim of this study was to identify genes that play a role in colorectal cancer (CRC) carcinogenesis by analysis of differential gene…”
    Get full text
    Journal Article
  4. 4

    Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner by DVORY-SOBOL, Hadas, COHEN-NOYMAN, Efrat, KAZANOV, Diana, FIGER, Arie, BIRKENFELD, Shlomo, MADAR-SHAPIRO, Liora, BENAMOUZIG, Robert, ARBER, Nadir

    Published in European journal of cancer (1990) (01-02-2006)
    “…A unique in vitro system has been developed in our lab that consists of normal enterocytes derived from the rat ileum (IEC-18 cells) and their transformed…”
    Get full text
    Journal Article
  5. 5

    Targeting the active β-catenin pathway to treat cancer cells by Dvory-Sobol, Hadas, Sagiv, Eyal, Kazanov, Diana, Ben-Ze'ev, Avri, Arber, Nadir

    Published in Molecular cancer therapeutics (01-11-2006)
    “…The adenomatous polyposis coli or β-catenin genes are frequently mutated in colorectal cancer cells, resulting in oncogenic activation of β-catenin signaling…”
    Get full text
    Journal Article
  6. 6

    Gene Expression Analysis Proposes Alternative Pathways for the Mechanism by Which Celecoxib Selectively Inhibits the Growth of Transformed but not Normal Enterocytes by SAGIV, Eyal, ROZOVSKI, Uri, KAZANOV, Diana, LIBERMAN, Eliezer, ARBER, Nadir

    Published in Clinical cancer research (15-11-2007)
    “…Purpose: Cyclooxygenase-2 inhibitor (celecoxib, Pfizer) is a promising chemopreventive agent, yet its long-term use may be limited due to increased…”
    Get full text
    Journal Article
  7. 7

    Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cells in Vitro by Kazanov, Diana, Dvory-Sobol, Hadas, Pick, Marjorie, Liberman, Eliezer, Strier, Ludmila, Choen-Noyman, Efrat, Deutsch, Varda, Kunik, Talya, Arber, Nadir

    Published in Clinical cancer research (01-01-2004)
    “…Purpose: Nonsteroidal anti-inflammatory drugs reduce the risk of colorectal cancer. The cyclooxygenase (COX) pathway of arachidonic acid metabolism is an…”
    Get full text
    Journal Article
  8. 8

    The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews by Boursi, Ben, Sella, Tal, Liberman, Eliezer, Shapira, Shiran, David, Maayan, Kazanov, Diana, Arber, Nadir, Kraus, Sarah

    Published in European journal of cancer (1990) (01-11-2013)
    “…The p.I1307K adenomatous polyposis coli (APC) gene variant, prevalent among Ashkenazi Jews, may increase the risk for colorectal neoplasia. We studied the…”
    Get full text
    Journal Article
  9. 9

    Selective eradication of cancer cells by delivery of adenovirus-based toxins by Shapira, Shiran, Shapira, Assaf, Kazanov, Diana, Hevroni, Gil, Kraus, Sarah, Arber, Nadir

    Published in Oncotarget (13-06-2017)
    “…KRAS mutation is an early event in colorectal cancer carcinogenesis. We previously reported that a recombinant adenovirus, carrying a pro-apoptotic gene (PUMA)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    APC I1307K polymorphism as a predictive factor for colorectal neoplasia recurrence by Boursi, Ben, Sella, Tal, Liberman, Eliezer, Geva, Ravit, Shmueli, Einat, Kazanov, Diana, Kraus, Sarah, Arber, Nadir

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only 1526 Background: The use of surveillance colonoscopy to detect disease recurrence after initial colorectal neoplasia resection has increased…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    The APC p. I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews by Boursi, Ben, Sella, Tal, Liberman, Eliezer, Shapira, Shiran, David, Maayan, Kazanov, Diana, Arber, Nadir, Kraus, Sarah

    Published in European journal of cancer (1990) (2013)
    “…Abstract Background The p.I1307K adenomatous polyposis coli ( APC ) gene variant, prevalent among Ashkenazi Jews, may increase the risk for colorectal…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20